• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Pet Medications in the U.S.: Over-the-Counter and Prescription Remedies as Consumer Products, 3rd Edition - Product Image

Pet Medications in the U.S.: Over-the-Counter and Prescription Remedies as Consumer Products, 3rd Edition

  • ID: 2780241
  • January 2014
  • Region: United States
  • 212 Pages
  • Packaged Facts

FEATURED COMPANIES

  • Aratana
  • Bayer
  • Elanco
  • Frontline
  • Merial
  • Novartis
  • MORE

The market for pet medications in the U.S. is experiencing considerable activity.

Longtime flea and tick leader Frontline (from Merial) is finally feeling the effects of the patent expiration of its active ingredient, fipronil. Several other fipronil products have made a splash, gnawing away at Frontline's market share. Meanwhile other flea/tick treatments are coming to the fore, such as Elanco's Trifexis, Bayer's new flea collar Seresto and Merial's new answer to its Frontline erosion – NexGard.

The interest in keeping our pets healthy has caught the attention of one important constituent – the investment community. Pfizer spun off its Animal Health unit (renamed Zoetis) in the largest IPO since Facebook. Novartis' Animal Health unit has drawn interest from several competitors. And Aratana, a now publicly traded biopharma focused on pet therapeutics, is leading a new wave of animal health start-ups.

All of this activity has gotten retailers interested. Pet medications have long been the domain of veterinary clinics. While this is still undoubtedly the most important channel, brick-and-mortar retailers and online retailers have gained ground.

In READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aratana
  • Bayer
  • Elanco
  • Frontline
  • Merial
  • Novartis
  • MORE

Chapter 1: Executive Summary

- Scope and Methodology
-- Market Definition
--- Product Regulation
-- Report Methodology
- Market Trends
- Market Size & Composition
-- U.S. Retail Sales of Pet Medications at $7.6 Billion in 2013
--Share of Sales by Distribution Channel
--- Figure 1-1: Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2013 (percent)
-- Market Outlook
--- Table 1-1: Projected U.S. Retail Sales of Pet Medications, 2013-2018 (in billions of dollars)
- Competitive Overview
-- Two Groups of Marketers
-- Pharmaceutical/Veterinary Channel Marketers
--- Table 1-2: Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2011-2012 (in millions of dollars)
-- Pet Product/Retail Marketers
-- Notable Deals
--- Pfizer Spins Off Animal Health Division
--- Perrigo Acquires Sergeant's, Then Velcera
--- Bayer Acquires Teva Animal Health
-- Aratana Leads the Way for New Entrants
-- In the Works
- Retail Trends
-- Channels Continue Diversification
-- Online Channel Expands
-- Target and Walmart Jump into Pet Prescriptions
-- 74% of Dog or Cat Owners Use Flea/Tick Products
-- Majority Of Pet Owners Choose Spot-On Flea/Tick Medications
-- 71% of Dog-Owning Households Use Heartworm Meds
--- Figure 1-2: Purchasing of Heartworm Medications by Channel, 2013 (percent of U.S. dog or cat owners)
-- Antibiotics Top List of Other Pet Medications
-- Attitudes on Veterinarian/Professional vs. Store Products
--- Table 1-3: Levels of Agreement with Statement, “I Trust the Pet Medications My Veterinarian Recommends”: Dog Owners vs. Cat Owners, 2013 (percent)

Chapter 2: Market Trends

- Market Size & Composition
-- U.S. Retail Sales of Pet Medications at $7.6 Billion in 2013
--- Table 2-1: U.S. Retail Sales of Pet Medications, 2009-2013 (in billions of dollars)
-- Share of Sales by Animal Type
--- Figure 2-1: Share of U.S. Retail Sales of Pet Medications by Animal Type: Dog vs. Cat, 2013 (percent)
-- Share of Sales by Distribution Channel
--- Figure 2-2: Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2013 (percent)
- Market Outlook
-- Many Positive Indicators
-- Human/Animal Bond Bolsters Pet Health/Wellness Spending
--- Table 2-2: Level of Veterinary Expenditures by Human-Animal Bond and Animal Type, 2011 (mean dollar per household)
--- Table 2-3: Mean Number of Veterinary Visits: By Human/Animal Bond Among Dog and Cat Households, 2011
--- Figure 2-3: Level of Agreement with Statement: “I buy pet supplements and/or functional treats to make doubly sure that my pet gets all the special nutrition it needs,” 2012 (percent)
-- Premium Demographics
--- Figure 2-4: $70K+ Household Share of U.S. Pet Market Expenditures: By Category, 2002 vs. 2012 (percent)
-- The Aging Pet Population
--- Table 2-4: Age of Dogs and Cats, 2014 (percent of pet owners)
--- Figure 2-5: Percentage of Dogs and Cats Age 6 and Over: 1987 vs. 2011 (percent)
-- Overweight and Obese Pets Keep Costs Up
--- Table 2-5: Percentage and Number of Overweight and Obese Dogs and Cats, 2012
--- Figure 2-6: Percent with an Overweight Pet: Dog vs. Cat Owners, 2014 (percent)
-- Global Pharmas Are Major Investors
-- Morris Animal Foundation Advances Veterinary Research
-- Pet Insurance Shows Double Digit Growth
--- Figure 2-7: Projected North American Pet Insurance Market Revenues: United States, Canada, and North America, 2013 vs. 2018 (in millions of U.S. dollars)
-- Cautiously Optimistic Consumers
--- Table 2-6: Selected U.S. Economic Measures: 2008-2013 (percent and number in millions)
--- Some Pet Owners Still Spending Less
--- Table 2-7: Level of Agreement with Statement: “I am spending less on pet products because of the economy,” 2010-2014 (percent)
--- Table 2-8: Economic Mood of U.S. Pet Households: 2009-2013 (percent)
--- Table 2-9: Economic Outlook of U.S. Pet Households: 2009-2013 (percent)
-- Overall Veterinary Visits Up, But Percentages Down
--- Dog Visits Up, But Fewer Dog Owners Visiting
--- Cat Visits Drop Some More
--- Efforts to Reverse Trend
--- Table 2-10: Percentage of Dog and Cat Owners Who Have Visited Vet in Past Year: Routine Checkup vs. Sick/Emergency Care, 2012 vs. 2014
-- Highly Competitive Flea/Tick Segment
--- Generics and Channel Competition
-- Competition from Holistic and Natural Treatments
--- Figure 2-8: U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Total, Small Animal (Dog, Cat, Other), Equine, 2008, 2012, 2017 (in millions of dollars)
--- Table 2-11: Use of Specialty Nutritional Formula Pet Food, Treats, and Pet Supplements: Dog Owners vs. Cat Owners, 2013 (percent)
--- Illustration 2-1: Hill's Prescription Diet Metabolic Pet Food Line
--- Table 2-12: Level of Agreement with Statements “If Natural/Organic Pet Products Were More Affordable / More Available Where I Shop, I Would Buy Them More Often,” 2013 (percent of U.S. pet owners)
- Looking Ahead
-- Projected Market Growth: Sales to Top $10 Billion in 2018
--- Table 2-13: Projected U.S. Retail Sales of Pet Medications, 2013-2018 (in billions of dollars)
--- Table 2-14: Economic Outlook of U.S. Pet Households: 2009-2013 (percent)

Chapter 3: The Marketers

- Competitive Overview
-- Two Groups of Marketers
-- Ten Leading Pharmaceutical/Veterinary Channel Marketers
--- Table 3-1: Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2011-2012 (in millions of dollars)
--- Table 3-2: Global Pharmaceutical Marketers by Dollar and Percentage Change in Global Sales: Total vs. Animal Health, 2011-2012 (in millions of dollars)
-- Pet Product/Retail Marketers
-- Notable Deals
--- Pfizer Spins Off Animal Health Division
--- Perrigo Acquires Sergeant's, Then Velcera
--- Bayer Acquires Teva Animal Health
--- Unicharm Takes Stake in Sumimoto's Hartz
-- Aratana Leads the Way For New Entrants
-- In the Works
-- Other Deals
--- Generic Pet Medications on the Rise
--- Generics Take on the Frontline Franchise
--- Putney Grows Its Pet Generics Portfolio
--- Illustration 3-1: Putney Inc. Screenshot
- Focus on Antiparasitics
-- Frontline Still Leads in Flea/Tick Sales
--- Table 3-3: Marketer Shares of U.S. Retail Sales of Flea & Tick Spot-Ons, 2013 (percent)
-- The Blockbuster of Animal Health
--- At the Cliff
-- Bayer Goes Rogue
--- New Generation Advantage II and K9 Advantix II
--- Advantage a Top Consumer Brand at Bayer
-- Zoetis and Revolution
-- The Novartis Portfolio
-- Elanco Innovations
-- Virbac Launches Fipronil Topicals
-- Ceva Fuels Growth with Vectra
-- Fipronil Wars: The Saga
--- Merial vs. Velcera
--- HVG and Ceva vs. Merial
-- A New Era of Creative Destruction
--- Merial's Silver Bullet
--- Illustration 3-2: Trade ad for Merial's NexGard
--- Bayer Reinvents the Flea Collar
--- Illustration 3-3: New Seresto Collar from Bayer
--- Merck Unveils Bioactivation
--- Illustration 3-4: Trade Ad for Merck's Activyl
-- Competitors Challenge Hartz in the Mass Tier
--- Table 3-4: IRI-tracked Sales of Pet Medications, 2013
-- Focus on Retail Flea/Tick Brands
--- Central Garden & Pet Down for the Year
--- Illustration 3-5: Adams Smart Shield
--- Retail Brands and Fipronil
--- Illustration 3-6: Hartz First Defense Topical for Cats Website
--- Sergeant's Offers Array of Brands
-- Trends in Advertising and Promotion
--- Illustration 3-7: Screen shot of Bayer's PetParents.com web site
--- Illustration 3-8: Seresto Reminder Service with Coupon
--- Bayer
--- Central Garden & Pet
--- Ceva Animal Health
--- Illustration 3-9: Screen Shot from Vectra Website
--- Elanco
--- Illustration 3-10: Trade ad for Elanco's Trifexis promoting consumer awareness campaign
--- FidoPharm
--- Hartz
--- Merial
--- Illustration 3-11: Frontline Branding in Pet Rescue Saga
--- Sergeant's
--- Zoetis
-- Focus on Heartworm Medications
--- Growing Industry Concerns about Heartworm Treatments
--- New Directions in Heartworm Testing and Treatment
--- Advertising and Promotion
--- Illustration 3-12: Screen shot for Merial's JoinPowerOf12.com web site
--- Illustration 3-13: Trade ad for Virbac's Iverhart Max
-- Broad Spectrum Wormers
- Trends in Developing Market Segments
-- Cancer
--- New Competitive Dynamics
-- Brain Health
--- Illustration 3-14: Pfizer CDSinDogs.com Website
-- Emotional/Behavioral Health
--- Market Pioneer: Clomicalm
--- Illustration 3-15: Screen Shot of Clomicalm Website
--- Reconcile: Prozac for Pets
--- Illustration 3-16: Screen Shot: Virbac Anxitane
--- Illustration 3-17: Screen Shot: Feliway L.O.V.E. Bus
-- Pain Management: A New Frontier
--- Major Brands
--- Illustration 3-18: Banner Ad for Merial's Previcox
--- Illustration 3-19: Screen Shot: Deramaxx Website
--- Illustration 3-20: Trade Ad for Abbott's OroCAM Spray-and-Go Formula
--- Illustration 3-21: Screen Shot: Onsior Pain Relief for Cats
--- Alternative Pain Treatments
--- Illustration 3-22: Screen Shot: Canna-Pet website for Canna-Cat and Canna-Canine
-- Pet Obesity and Diabetes
--- Slentrol
--- Illustration 3-23: Screen Shot: Zoetis Slentrol
--- Diabetes Support
--- Illustration 3-24: Screen Shot: Vetsulin Website
--- Illustration 3-25: Screen Shot: ProZinc Website
-- Heart Health
--- Illustration 3-26: Trade Ad for Boehringer Ingelheim Vetmedica's Vetmedin
-- Ear Infections
--- Illustration 3-27: Trade Ad for Virbac's EasOtic
-- Allergy Treatments Bloom
--- Illustration 3-28: Screen Shot: The Itch Cycle
-- Retail/OTC Pet Medications
--- Alternative Treatment Options
--- Homeopathic Remedies
--- Ear Cleaning Products
--- Table 3-5a: Selected Leading Pharmaceutical Marketers and Brands of Pet Medications: Product Type and Generic Drug Name, 2013
--- Table 3-5b: Selected Leading Pharmaceutical Marketers and Brands of Pet Medications: Status, Form, Animal Type and Description, 2013
--- Table 3-6: Selected Leading Retail Marketers and Brands of Pet Medications, 2013

Chapter 4: Retail Trends

- Modern Consumers ChallengeDistribution Structure
- Channels Continue Diversification
- Pethealth Tracks Channel Choices Among Pet Adopters
- Online Channel Expands
-- Illustration 4-1: FetchRx's LivingSocial Promotion
- Vet-VIPPS Participation Grows
- Companies Create Online Pharmacies for Veterinary Practices
-- Illustration 4-2: Vets First Choice Home Page
- PetMed Express Slumping, But Analysts Optimistic
-- Table 4-1: PetMed Express Sales, 2007-2013 (in millions of dollars)
-- Table 4-2: Share of PetMed Express Sales by Category: 2007, 2009, 2011, 2013 (percent)
- Veterinarians Confront PetMed Express
-- Illustration 4-3: 1800PetMeds.com TV Commercial
- Amazon's Wag.com Takes On PetMed Express
-- Illustration 4-4: Wag.com's Pet Medications home page
- Target Emphasizes Pets
-- Illustration 4-5: PetRx on Target's website
- Pet Meds at Walmart
- Other Mass Retailers Join the Party
-- Illustration 4-6: Pet Department Endcap in Walgreens— “Pet Meds Covered”
-- Illustration 4-7: Pet Medications on Walgreens.com
- Fairness to Pet Owners Act Dies, For Now
- Flea & Tick Category Explodes in Pet Specialty Channel
- Pet Specialty Online
- Pet Specialty Eyeing Prescription Meds
-- Illustration 4-8: PetSmart.com's Pet Pharmacy
- Supplements at Specialty Retail
-- Illustration 4-9: GNC Pet Multivitamin Plus
-- Illustration 4-10: Petco Brewer's Yeast & Garlic Tablets
-- Table 4-3: Selected Leading Third-Party E-tailers of Pet Medications, 2013

Chapter 5: Consumer Trends

- Pet Medication Purchasing Patterns
-- 74% of Dog or Cat Owners Use Flea/Tick Products
--- Table 5-1: Percent of Dog or Cat Owners Who Purchase Flea & Tick Care Medications or Medicated Products, 2010-2013 (U.S. dog- or cat-owning households in thousands)
-- Majority Of Pet Owners Choose Spot-On Flea/Tick Medications
--- Figure 5-1: Purchasing of Flea & Tick Care Medications: Share by Product Type, 2013 (percent of U.S. dog or cat owners)
--- Figure 5-2: Purchasing of Spot-On Flea & Tick Care Medications by Channel, 2013 (U.S. dog or cat owners)
-- Frontline Draws Almost Half of Spot-On Purchasers
--- Table 5-2: Share of Spot-On Flea & Tick Care Medication Purchasers by Brand, 2013 (U.S. dog or cat owners)
-- Natural Flea & Tick Product Usage
-- Demographics for Flea & Tick Brands
--- Table 5-3a: Index for Use of Flea/Tick Products by Brand, 2013 (U.S. dog- or cat-owning households)
--- Table 5-3b: Index for Use of Flea/Tick Products by Brand, 2013 (U.S. dog- or cat-owning households)
-- Sentinel Draws 38% of Oral Flea/Tick Medication Purchasers
--- Figure 5-3 Share of Oral Flea & Tick Care Medication Purchasers by Brand, 2013 (percent of U.S. dog or cat owners)
-- 71% of Dog-Owning Households Use Heartworm Meds
--- Table 5-4: Index for Use of Heartworm Control Medications for Dogs, 2013
--- Figure 5-4: Purchasing of Heartworm Medications by Channel, 2013 (percent of U.S. dog or cat owners)
-- Heartgard Draws Half of Heartworm Medication Purchasers
--- Figure 5-5: Share of Heartworm Control Medication Purchasers by Brand, 2013 (percent of U.S. dog or cat owners)
-- Antibiotics Top List of Other Pet Medications
--- Table 5-5: Use by Type of Selected Other Pet Medications for Dogs and Cats, 2013 (percent)
--- Table 5-6: Purchasing by Channel of Selected Other Pet Medications for Dogs, 2013 (percent)
--- Table 5-7: Purchasing by Channel of Selected Other Pet Medications for Cats, 2013 (percent)
-- For Spot-On Flea/Tick, Pet Superstores and Mass Retailers Lead Brick & Mortar Retailers
--- Table 5-8: Purchasing of Spot-on Flea/Tick Care Medications by Retail Store or Channel: Dog Owners, 2013 (percent)
-- Amazon Shows Highest Online Draw
--- Table 5-9: Purchasing of Dog and Cat Medications by Online Source, 2013 (percent)
-- Benadryl Is Human OTC Med Most Commonly Used for Pets
- Pet Med Psychographics
-- No General Trend Toward Increased Use of Pet Meds
--- Table 5-10: Levels of Agreement/Disagreement with Statement, “I Am Buying More Pet Medications Than I Used To”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-11: Levels of Agreement/Disagreement with Statement “The Current Range of Pet Medications Is Not Adequate”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-12: Levels of Agreement/Disagreement with Statement, “I Am Interested in New Types of Pet Medications”: Dog Owners vs. Cat Owners, 2013 (percent)
-- Age- and Weight-Related Triggers for Pet Meds
--- Table 5-13: Levels of Agreement/Disagreement with Statement, “Age-Related Conditions Are the Cause of Some of the Pet
--- Medications That I Buy”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-14: Levels of Agreement/Disagreement with Statement, “Weight/Obesity-Related Conditions Are the Cause of Some of the Pet Medications That I Buy”: Dog Owners vs. Cat Owners, 2013 (percent)
-- Attitudes on Veterinarian/Professional vs. Store Products
--- Table 5-15: Levels of Agreement/Disagreement with Statement, “I Trust the Pet Medications My Veterinarian Recommends”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-16: Levels of Agreement/Disagreement with Statement, “I Trust the Pet Medications Available at the Stores Where I Buy Pet Products”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-17: Levels of Agreement/Disagreement with Statement, “With Spot-On (Topical) Flea/Tick Products, the Products Available in Stores Are Just as Effective as Those Available Through Veterinarians”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-18: Levels of Agreement/Disagreement with Statement, “With Spot-On (Topical) Flea/Tick Products, I Would Trust Generic or Store-Brand Products if They Contained the Same Active Ingredients”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-19: Levels of Agreement/Disagreement with Statement, “Veterinarian-Dispensed Spot-On (Topical) Flea/Tick Products Are Too Expensive”: Dog Owners vs. Cat Owners, 2013 (percent)
-- Resistance and Alternatives to Pet Meds
--- Table 5-20: Levels of Agreement/Disagreement with Statement, “I Avoid Using Pet Medications as Much as Possible”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-21: Levels of Agreement/Disagreement with Statement, “I Prefer to Try Holistic/Natural Pet Treatments Including Nutritional Supplements Before Resorting to Pet Medications”: Dog Owners vs. Cat Owners, 2013 (percent)
--- Table 5-22: Levels of Agreement/Disagreement with Statement, “High-Quality Pet Foods Are Effective as a Preventive Pet Health Treatment”: Dog Owners vs. Cat Owners, 2013 (percent)

Note: Product cover images may vary from those shown

- Aratana
- Bayer
- Elanco
- Frontline
- Merial
- Novartis
- Pfizer

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

ALSO AVAILABLE

  • Canadian Pet Market Outlook, 2014 - Product Thumbnail Image

    Canadian Pet Market Outlook, 2014

    • Language: English
    • 168 Pages
    • Published: January 2014
    • Region: Canada
    FROM

RELATED PRODUCTS

Our Clients

Our clients' logos